haplo-identical
Showing 26 - 50 of 1,066
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +7 more
- decitabine
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Mar 5, 2020
GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)
Completed
- GVHD, Acute
- PT-CY-FK +/-ATG
-
Shanghai, Shanghai, ChinaRui Jin Hospital
May 19, 2021
Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancy
- Bone Marrow Transplant
- Tocilizumab
- +4 more
-
New York, New YorkWeill Cornell Medical College
Oct 27, 2021
Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic
Not yet recruiting
- Refractory Idiopathic Aplastic Anemia
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
- Allogenic transplantation
- (no location specified)
Nov 8, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)
Enrolling by invitation
- Acute Lymphoblastic Leukemia
- +2 more
- CliniMacs TCR alpha-beta-Biotin system
-
Los Angeles, California
- +9 more
Feb 10, 2022
Hematopoietic Stem Cell Transplant Trial in Paris (transplant from a haplo-identical donor, transplant from a non related donor)
Recruiting
- Hematopoietic Stem Cell Transplant
- transplant from a haplo-identical donor
- transplant from a non related donor
-
Paris, France
- +1 more
Feb 18, 2019
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Haplo-Cord Transplant
- Matched Unrelated Donor Transplant
-
Chicago, IllinoisUniversity of Chicago Cancer Center
Feb 22, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Cyclophosphamide
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
Acute Leukemia, MDS Trial in Beijing (Cytarabine)
Recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking University, Institute of Hematolgoy
Sep 23, 2020
GVHD in the Setting of Haplo-HSCT Trial in Fuzhou (Immunosuppressive Agent)
Unknown status
- GVHD in the Setting of Haplo-HSCT
- Immunosuppressive Agent
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 13, 2018
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial run by the NHLBI (Miltenyi
Completed
- Leukemia, Myeloid, Acute
- +2 more
- Miltenyi Magnetic cell sorter for CD3
-
Bethesda, MarylandNational Institutes of Health
Oct 7, 2020
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)
Terminated
- Acute Myelogenous Leukemia
- +4 more
- CliniMACS® CD34 Reagent System
- +5 more
-
New York, New YorkWeill Cornell Medical College
Jun 12, 2018
Leukemia, Lymphoma Trial in Houston (HSCT, DLI)
Completed
- Leukemia
- Lymphoma
- HSCT
- DLI
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 9, 2021
Kidney Failure, Chronic, Renal Insufficiency Trial in Boston (drug, radiation, procedure)
Completed
- Kidney Failure, Chronic
- Renal Insufficiency
- Belatacept
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital
Oct 4, 2021
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)
Terminated
- Mantle Cell Lymphoma
- +4 more
- cellular immunotherapy
-
Providence, Rhode Island
- +1 more
Feb 23, 2022
Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,
Recruiting
- Acute Leukemia
- Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
- haploidentical hematopoietic stem cell transplantation
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 9, 2022
Cytomegalovirus Infection After HSCT and PT-CY as GVHD
Completed
- CMV Infection
-
Malaga, SpainMaria Jesus Pascual
Mar 30, 2022
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)
Recruiting
- High-risk Leukemias
- NK cells stimulated ex vivo with IL-15
- Alloreactive NK cells
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Mar 30, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Suzhou (Individual ATG, ATG)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Acute Leukemia
- Individual ATG
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 12, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022